- EMEA
- About us
- Our responsibilities
- Our responsibility to the planet
- Value of Health Futureproofing healthcare
Value of Health
Futureproofing healthcare
Futureproofing healthcare
At J&J, we understand our dual responsibility to patients: to develop the next generation of medicines across a vast continuum of diseases for the patients of tomorrow and to help support affordable access to our medicines.
Transforming Health. J&J leaders discuss the value of innovative medicines for patients and society, and the importance of future-proofing healthcare across EMEA.
Articles
Podcasts
Listen to Martin Price, VP Health Economics, Market Access and Reimbursement, EMEA
Webinars
Watch Jennifer Lee, Senior Director, Market Access EMEA and a panel of experts on the Economist Cell & Gene Therapy Insight hour
Access and pricing principles
Medicines can only help if people can get them. Every step of our journey means nothing if our medicine does not reach its final destination.
We help navigate increasingly complex healthcare systems and continue to work to enable local patient access to transformational medical innovation now and in the future.
We help navigate increasingly complex healthcare systems and continue to work to enable local patient access to transformational medical innovation now and in the future.
Three guiding principles drive our pricing decisions.
J&J Innovative Medicine constantly strives to maintain reasonable prices by delivering local value, collaborating with payers and governments to offer accessible and affordable medicines, fueling sustainable innovation.
-
The value our medicines bring is in improving the lives of patients and transforming their health for the future.
We strive to deliver transformational medicines that improve the lives and health of patients. Our medicines help people live longer and improve their quality of life. We work closely with payers such as governments, insurers and other local stakeholders to negotiate the price of our medicines based on their local value — prioritizing health outcomes and the impact our medicines have on a specific society and economy. -
Sustaining the discovery, development and delivery of transformational medicines is necessary to improve lives for current and future patients in need.
When we succeed at delivering valuable medicines with transformational outcomes, individual patients thrive, and families, countries, communities and societies flourish. Enabling investment in innovation to discover, develop and deliver medicines provides significant benefit to patients today and tomorrow. Fair pricing for valuable therapies fuels the next breakthroughs and cures. -
Through active collaboration, we make our medicines readily accessible and affordable for patients and health systems in accordance with specific reimbursement systems and legal guidelines of local communities.
Countries and health systems around the world differ in how they pay for medicines and make them accessible to their citizens. Knowing this, we work with governments and payers, as early as the law allows, to discuss coverage, accelerate availability and provide the best possible access to our medicines. After all, medicines only deliver value when they reach patients who need them.
